MedTrace Logo

Continuous Monitoring and Control of Hypoglycemia

NCT03340831 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1388

Last updated 2021-09-21

No results posted yet for this study

Summary

Evaluate safety of non-adjunctive CGM use in CGM naive participants.

Conditions

Interventions

DEVICE

Continuous Glucose Monitoring (CGM)

Use of CGM to compare incidence of diabetes events compared to use of a blood glucose meter (BGM)

Sponsors & Collaborators

  • DexCom, Inc.

    lead INDUSTRY

Principal Investigators

  • David Price, MD · Dexcom-Medical Affairs

Eligibility

Min Age
2 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-20
Primary Completion
2023-12-30
Completion
2023-12-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03340831 on ClinicalTrials.gov